← Leaderboards
Barry Coller
Rockefeller University
$100,984,073
Attributed
$100,984,073
Total exposure
42
Grants
39
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $20.2M · FY2005–25$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$204,285,145 · 46
By mechanism
UL1$167,014,308 · 36
R01$16,725,274 · 1
KL2$10,423,181 · 4
M01$9,218,597 · 2
P50$563,785 · 1
S07$300,000 · 1
Top collaborators
- James G Krueger5 shared
Others in their field
Top investigators on “Translational Research”
- Leonard Freedman · Leidos Biomedical Research, Inc.$362,430,297
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$293,499,096
- Steven E Reis · University Of Pittsburgh At Pittsburgh$280,623,952
- David Heimbrook · Leidos Biomedical Research, Inc.$270,029,156
- Gregory H Reaman · National Childhood Cancer Foundation$259,780,965
- Lee Marshall Nadler · Dana-Farber Cancer Inst$240,966,783
Research focus
Translational ResearchClinical ResearchProgramsUniversitiesResearch PersonnelCommunitiesStructureResourcesParticipantResearch InfrastructurePhenotypeDesignClinical SciencesDiagnosisBaseGrantMedicalInnovationThrombosisTrainingIntegrinsMonitorMolecularHospitals
Grant awards (118)
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success$3,671,021
UL1 · FY2025 · TR · contact PI
Platelet Integrin AlphaIIbBeta3 Structure, Activation, and Ligand Binding: Fibrinogen, Fibrin, D-dimer, and von Willebrand Factor$759,040
R01 · FY2025 · HL · contact PI
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success$3,669,160
UL1 · FY2024 · TR · contact PI
Platelet Integrin AlphaIIbBeta3 Structure, Activation, and Ligand Binding: Fibrinogen, Fibrin, D-dimer, and von Willebrand Factor$743,861
R01 · FY2024 · HL · contact PI
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success$2,775,381
UL1 · FY2023 · TR · contact PI
Platelet Integrin AlphaIIbBeta3 Structure, Activation, and Ligand Binding: Fibrinogen, Fibrin, D-dimer, and von Willebrand Factor$759,040
R01 · FY2023 · HL · contact PI
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success$3,681,571
UL1 · FY2022 · TR · contact PI
Platelet Integrin AlphaIIbBeta3 Structure, Activation, and Ligand Binding: Fibrinogen, Fibrin, D-dimer, and von Willebrand Factor$776,645
R01 · FY2022 · HL · contact PI
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success$3,671,021
UL1 · FY2021 · TR · contact PI
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success$3,639,604
UL1 · FY2020 · TR · contact PI
Core-001$884,937
UL1 · FY2020 · TR · contact PI
Beta3 Integrins - Translation of Molecular Structure to Improved Therapeutics$783,775
R01 · FY2020 · HL · contact PI
Core-003$782,413
UL1 · FY2020 · TR · contact PI
Core-005$772,416
UL1 · FY2020 · TR · contact PI
Core-006$496,974
UL1 · FY2020 · TR · contact PI
Core-004$432,121
UL1 · FY2020 · TR · contact PI
Core-002$270,743
UL1 · FY2020 · TR · contact PI
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success$3,565,806
UL1 · FY2019 · TR · contact PI
Institutional Career Development Core$931,073
KL2 · FY2019 · TR · contact PI
Beta3 Integrins - Translation of Molecular Structure to Improved Therapeutics$808,046
R01 · FY2019 · HL · contact PI
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success$4,334,033
UL1 · FY2018 · TR · contact PI
Institutional Career Development Core$906,432
KL2 · FY2018 · TR · contact PI
Beta3 Integrins - Translation of Molecular Structure to Improved Therapeutics$799,129
R01 · FY2018 · HL · contact PI
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success$484,268
UL1 · FY2018 · TR · contact PI
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success$5,151,440
UL1 · FY2017 · TR · contact PI
Institutional Career Development Core$897,515
KL2 · FY2017 · TR · contact PI
Beta3 Integrins - Translation of Molecular Structure to Improved Therapeutics$848,310
R01 · FY2017 · HL · contact PI
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success$5,911,836
UL1 · FY2016 · TR · contact PI
Institutional Career Development Core$876,444
KL2 · FY2016 · TR · contact PI
Integrin alphaIIbbeta3 Structure, Activation, and Ligand Binding$621,817
R01 · FY2016 · HL · contact PI
Transforming Translational Science and Education to Benefit Human Health$6,672,713
UL1 · FY2015 · TR · contact PI
Integrin alphaIIbbeta3 Structure, Activation, and Ligand Binding$612,489
R01 · FY2015 · HL · contact PI
Transforming Translational Science and Education to Benefit Human Health$546,614
KL2 · FY2015 · TR · contact PI
Transforming Translational Science and Education to Benefit Human Health$42,275
UL1 · FY2015 · TR · contact PI
Transforming Translational Science and Education to Benefit Human Health$6,690,125
UL1 · FY2014 · TR · contact PI
Integrin alphaIIbbeta3 Structure, Activation, and Ligand Binding$609,382
R01 · FY2014 · HL · contact PI
Transforming Translational Science and Education to Benefit Human Health$529,202
KL2 · FY2014 · TR · contact PI
Transforming Translational Science and Education to Benefit Human Health$127,125
UL1 · FY2014 · TR · contact PI
Transforming Translational Science and Education to Benefit Human Health$6,164,376
UL1 · FY2013 · TR · contact PI
Integrin alphaIIbbeta3 Structure, Activation, and Ligand Binding$615,725
R01 · FY2013 · HL · contact PI
Transforming Translational Science and Education to Benefit Human Health$518,917
KL2 · FY2013 · TR · contact PI
Transforming Translational Science and Education to Benefit Human Health$6,719,343
UL1 · FY2012 · TR · contact PI
Integrin alphaIIbbeta3 Structure, Activation, and Ligand Binding$669,805
R01 · FY2012 · HL · contact PI
Transforming Translational Science and Education to Benefit Human Health$499,984
KL2 · FY2012 · TR · contact PI
Transforming Translational Science and Education to benefit human health$416,808
UL1 · FY2012 · TR · contact PI
Transforming Translational Science and Education to Benefit Human Health$6,742,127
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$2,475,964
UL1 · FY2011 · RR · contact PI
TRANSFORMING TRANSLATIONAL SCIENCE AND EDUCATION TO BENEFIT HUMAN HEALTH$2,475,963
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,127,454
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,127,454
UL1 · FY2011 · RR · contact PI
Integrin alphaIIbbeta3 Structure, Activation, and Ligand Binding$671,029
R01 · FY2011 · HL · contact PI
Transforming Translational Science and Education to Benefit Human Health$493,737
UL1 · FY2011 · RR · contact PI
Transforming Translational Science and Education to Benefit Human Health$477,200
KL2 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$309,524
UL1 · FY2011 · RR · contact PI
Transforming Translational Science and Education to Benefit Human Health$280,495
UL1 · FY2011 · RR · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$8,291,529
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$3,316,612
UL1 · FY2010 · RR · contact PI
TRANSFORMING CLINICAL AND TRANSLATIONAL RESEARCH AND EDUCATION AT ROCKEFELLER$2,072,882
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,243,730
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,243,729
UL1 · FY2010 · RR · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$1,192,282
KL2 · FY2010 · RR · contact PI
Integrin alphaIIbbeta3 Structure, Activation, and Ligand Binding$676,081
R01 · FY2010 · HL · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$414,576
UL1 · FY2010 · RR · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$8,129,192
UL1 · FY2009 · RR · contact PI
TRANSFORMING CLINICAL AND TRANSLATIONAL RESEARCH AND EDUCATION AT ROCKEFELLER$2,720,678
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$2,720,678
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,173,856
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,173,855
UL1 · FY2009 · RR · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$1,050,598
KL2 · FY2009 · RR · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$750,638
UL1 · FY2009 · RR · contact PI
Integrin alphaIIbbeta3 Structure, Activation, and Ligand Binding$677,611
R01 · FY2009 · HL · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$618,491
UL1 · FY2009 · RR · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$418,361
UL1 · FY2009 · RR · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$384,124
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$340,125
UL1 · FY2009 · RR · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$7,957,771
UL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$3,138,194
UL1 · FY2008 · RR · contact PI
TRANSFORMING CLINICAL AND TRANSLATIONAL RESEARCH AND EDUCATION AT ROCKEFELLER$3,138,194
UL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,439,129
UL1 · FY2008 · RR · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$918,000
KL2 · FY2008 · RR · contact PI
Integrin alphaIIbbeta3 Structure, Activation, and Ligand Binding$680,012
R01 · FY2008 · HL · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$392,254
UL1 · FY2008 · RR · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$150,000
UL1 · FY2008 · RR · contact PI
High Throughput Screen for Novel Inhibitors of Platelet Integrin alphaIIb-beta3$15,000
R03 · FY2008 · MH · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$8,376,601
UL1 · FY2007 · RR · contact PI
TRANSFORMING CLINICAL AND TRANSLATIONAL RESEARCH AND EDUCATION AT ROCKEFELLER$3,350,640
UL1 · FY2007 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$3,350,640
UL1 · FY2007 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,256,490
UL1 · FY2007 · RR · contact PI
Beta-3 Integrins in Platelet and Vasoocclusive Disorders$616,958
R01 · FY2007 · HL · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$613,980
KL2 · FY2007 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$418,831
UL1 · FY2007 · RR · contact PI
High Throughput Screen for Novel Inhibitors of Platelet Integrin alphaIIb-beta3$25,000
R03 · FY2007 · MH · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$6,486,140
UL1 · FY2006 · RR · contact PI
TRANSFORMING CLINICAL AND TRANSLATIONAL RESEARCH AND EDUCATION AT ROCKEFELLER$4,215,991
UL1 · FY2006 · RR · contact PI
GENERAL CLINICAL RESEARCH CENTER$4,046,859
M01 · FY2006 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$972,921
UL1 · FY2006 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$972,921
UL1 · FY2006 · RR · contact PI
Beta-3 Integrins in Platelet and Vasoocclusive Disorders$619,630
R01 · FY2006 · HL · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$324,307
UL1 · FY2006 · RR · contact PI
Transforming Clinical and Translational Research and Education at Rockefeller$232,470
KL2 · FY2006 · RR · contact PI
CTSA: K12 COMPONENT$232,470
KL2 · FY2006 · RR · contact PI
GENERAL CLINICAL RESEARCH CENTER$5,135,336
M01 · FY2005 · RR
Beta-3 Integrins in Platelet and Vasoocclusive Disorders$703,378
R01 · FY2005 · HL
Platelet leukocyte interactions in vascular disease$140,818
P50 · FY2005 · HL
STUDIES OF THE INTERACTIONS AMONG NORMAL AND ABNORMAL BLOOD CELLS$32,068
M01 · FY2005 · RR
Beta-3 Integrins in Platelet and Vasoocclusive Disorders$609,904
R01 · FY2004 · HL
Platelet leukocyte interactions in vascular disease$138,203
P50 · FY2004 · HL
Integrin Biogenesis in Human ES-derived Megakaryocytes$84,292
R01 · FY2004 · HL
Studies of the interactions among normal and abnormal blood cells...$4,334
M01 · FY2004 · RR
Beta-3 Integrins in Platelet and Vasoocclusive Disorders$593,622
R01 · FY2003 · HL
Novel On-line Education in Protection of Human Subjects$150,000
S07 · FY2003 · RR
BIOCHEMISTRY/PHYSIOLOGY OF PLATELET MEMBRANE RECEPTORS$471,316
R01 · FY2002 · HL
Information Technology To Enhance IRB Functions$150,000
S07 · FY2002 · RR
Platelet leukocyte interactions in vascular disease$0
P50 · FY2002 · HL
BIOCHEMISTRY/PHYSIOLOGY OF PLATELET MEMBRANE RECEPTORS$459,547
R01 · FY2001 · HL
Platelet leukocyte interactions in vascular disease$130,807
P50 · FY2001 · HL
BIOCHEMISTRY/PHYSIOLOGY OF PLATELET MEMBRANE RECEPTORS$454,830
R01 · FY2000 · HL
ANTIPLATELET AGENTS AS ANTICOAGULANTS$153,957
P50 · FY2000 · HL